#United States #Campbell #Verge Medical #Wavella #Ostial Corporation

Verge Medical Emerges as a Leader in Vascular Innovation

Verge Medical, the new identity of Ostial Corporation, has officially announced a significant development in its operational landscape. Following the strategic acquisition of Wavella™ technology from Crossfire Medical, Verge Medical is now poised to make substantial advancements in the fields of coronary and peripheral vascular interventions. This transformation not only marks a new chapter for the company but signifies a broader commitment to improving patient outcomes and procedural efficiency through innovative medical solutions.

What is Wavella™ Technology?

Wavella is an advanced specialty infusion catheter designed specifically to enhance procedural efficiency and patient comfort during venous applications. This cutting-edge device utilizes a unique rotating sinusoidal wire, enabling simultaneous delivery of physician-specified agents. By ensuring comprehensive and segmental agent delivery within the peripheral vasculature, Wavella has the potential to redefine standard practices in vascular interventions.

Mike Buck, CEO of Verge Medical, shared his enthusiasm regarding the transition: "We are excited to launch Verge Medical as the next chapter in our company's evolution. This acquisition expands our growing portfolio, reshaping the future of vascular interventions by enhancing coronary and peripheral treatments while optimizing procedural efficiency, safety, and patient outcomes. Verge Medical is actively pursuing additional medical device innovations to expand its pipeline and advance its mission."

Advancements and Offerings

In conjunction with the launch of its new identity, Verge Medical has also introduced its first commercial product, the FLASH™ Aorto-Ostial Angioplasty System. This innovative system has already been utilized in over 25,000 procedures, proving its effectiveness in the medical field. The Ostial FLASH System is designed to enable unparalleled 360° lesion coverage, facilitating more streamlined vessel reaccess that enhances patient outcomes significantly.

The integration of Wavella technology with the FLASH Aorto-Ostial Angioplasty System positions Verge Medical at the forefront of vascular innovation. The company is committed to providing healthcare professionals with technologies designed to enhance procedural outcomes and elevate patient care standards.

Future Vision

Looking ahead, Verge Medical is set on a path of ambition and growth. The company has expressed its intent not only to improve existing medical devices but also to innovate further within the realm of vascular intervention technologies. Mike Buck emphasized that extending the company's pipeline with additional innovative medical devices aligns with their overall mission of advancing healthcare practices.

The Wavella system, currently an investigational device, showcases Verge Medical's dedication to refining surgical interventions while prioritizing safety and efficacy. As the healthcare landscape continues to evolve, the demand for cutting-edge medical technology becomes increasingly essential. Verge Medical's proactive approach aims to meet these needs and contribute to the betterment of patient care worldwide.

About Verge Medical

Based in Campbell, California, Verge Medical is a private medical technology company that strives to transform vascular interventions through innovative solutions. Their commitment to enhancing procedural efficiency, safety, and clinical outcomes serves as the driving force behind their operational activities. To learn more about Verge Medical and its offerings, visit www.vergemedical.com.

With ongoing advancements and a focus on superior patient outcomes, Verge Medical is on track to become a significant player in the medical technology sector, ensuring that clinicians have access to the best possible tools for successful vascular interventions.